16:13 EDT Aravive files $250M mixed securities shelf
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on ARAV:
- Aravive Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)
- Aravive To Participate in the Jefferies Global Healthcare Conference
- Aravive Announces Phase 3 Trial Design for Batiraxcept in Clear Cell Renal Cell Carcinoma
- Aravive to Host Virtual KOL Event on its Late-Stage Oncology Asset Batiraxcept
- Is ARAV a Buy, Before Earnings?